相关实验视频
Updated: Jan 11, 2026

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
9.3K
口服免疫疗法抑制了对花生过敏的外围血液对花生的转录性反应
Lingdi Zhang1, Yoojin Chun1, Kyle Reed1
1Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
The Journal of allergy and clinical immunology
|November 13, 2025
概括
对花生过敏的口服免疫疗法 (OIT) 通过抑制免疫反应来使患者变得不敏感. 机器学习确定了预测成功OIT的关键基因转录,提供了潜在的治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 过敏研究 研究过敏
背景情况:
- 花生过敏是一种普遍的疾病,缺乏确定的治疗方法.
- 口服免疫疗法 (OIT) 显示出对脱敏的承诺,但其潜在机制需要阐明.
研究的目的:
- 为了研究OIT在花生过敏儿童中诱导的周围血液转录组变化.
- 为了识别与OIT诱导的脱敏相关的分子特征.
主要方法:
- 一项随机试验,涉及73名花生过敏的儿童接受OIT或花生避免治疗.
- 在多个时间点进行外周血液RNA测序和机器学习分析.
- 双盲,安慰剂控制的食物挑战,以评估临床结果.
主要成果:
- 100%的OIT参与者实现了脱敏,而避免组的这一比例为21%.
- OIT抑制了中性粒细胞脱粒和IL-4/IL-13信号通路.
- 机器学习识别了27个成绩单,以80%的准确度对OIT脱敏感性进行分类,包括FOS和NDST1.
结论:
- OIT有效地抑制了花生诱导的转录反应,与临床脱敏相关.
- 通过机器学习识别的特定基因转录作为OIT成功的准确生物标志物.
- 这些发现提高了对OIT机制的理解,并提出了对花生过敏的新疗法目标.
关键词:
它们有IL-13和IL-13.IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL is is is is is what is what is what is what is what is what is对于花生过敏的过敏人工智能的人工智能是人工智能.脱敏感化 脱敏感化食物过敏 食物过敏机器学习是机器学习.中性粒细胞的脱粒化.口服免疫疗法是口服免疫疗法.周围血液转录基因组相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Allergic Reactions
31.9K
Overview
31.9K
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Hypersensitivities
7.2K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.2K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Cross-reactivity
32.8K
Overview
32.8K

